Leafbuyer Technologies (OTCMKTS:LBUY) versus Astrana Health (NASDAQ:ASTH) Head-To-Head Review

Astrana Health (NASDAQ:ASTH) and Leafbuyer Technologies (OTCMKTS:LBUY) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their valuation, risk, dividends, analyst recommendations, profitability, institutional ownership and earnings.

Earnings & Valuation

This table compares Astrana Health and Leafbuyer Technologies’ gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Astrana Health	$1.39 billion	1.50	$60.72 million	$1.32	28.34
Leafbuyer Technologies	$5.09 million	0.53	-$580,000.00	N/A	N/A

Astrana Health has higher revenue and earnings than Leafbuyer Technologies.

Analyst Ratings

This is a breakdown of recent ratings and price targets for Astrana Health and Leafbuyer Technologies, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Astrana Health	0	1	1	0	2.50
Leafbuyer Technologies	0	0	0	0	N/A

Astrana Health presently has a consensus price target of $47.00, suggesting a potential upside of 25.63%. Given Astrana Health’s higher possible upside, research analysts clearly believe Astrana Health is more favorable than Leafbuyer Technologies.

Risk & Volatility

Astrana Health has a beta of 1.09, meaning that its share price is 9% more volatile than the S&P 500. Comparatively, Leafbuyer Technologies has a beta of 0.89, meaning that its share price is 11% less volatile than the S&P 500.

Institutional & Insider Ownership

52.8% of Astrana Health shares are owned by institutional investors. Comparatively, 11.0% of Leafbuyer Technologies shares are owned by institutional investors. 8.5% of Astrana Health shares are owned by company insiders. Comparatively, 24.4% of Leafbuyer Technologies shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Profitability

This table compares Astrana Health and Leafbuyer Technologies’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Astrana Health	4.49%	11.52%	6.67%
Leafbuyer Technologies	-18.38%	N/A	-59.79%

Summary

Astrana Health beats Leafbuyer Technologies on 10 of the 11 factors compared between the two stocks.

About Astrana Health

Astrana Health, Inc., Inc., a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians and extenders, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients. The company was formerly known as Apollo Medical Holdings, Inc. and changed its name to Astrana Health, Inc. in February 2024. Astrana Health, Inc. was incorporated in 1985 and is headquartered in Alhambra, California.

About Leafbuyer Technologies

Leafbuyer Technologies, Inc., through its subsidiary, LB Media Group, LLC, provides online resources for cannabis deals and specials in the United States. The company was founded in 2012 and is headquartered in Greenwood Village, Colorado.